0000950103-25-013417.txt : 20251021
0000950103-25-013417.hdr.sgml : 20251021
20251021080017
ACCESSION NUMBER: 0000950103-25-013417
CONFORMED SUBMISSION TYPE: SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20251021
DATE AS OF CHANGE: 20251021
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Innate Pharma SA
CENTRAL INDEX KEY: 0001598599
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
EIN: 000000000
STATE OF INCORPORATION: I0
FISCAL YEAR END: 1231
LEGAL ENTITY IDENTIFIER: 9695002Y8420ZB8HJE29
FILING VALUES:
FORM TYPE: SCHEDULE 13G/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-91173
FILM NUMBER: 251405386
BUSINESS ADDRESS:
ADDRESS IS A NON US LOCATION: YES
STREET 1: 117 AVENUE DE LUMINY
STREET 2: BP 30191
CITY: MARSEILLE
NON US STATE TERRITORY: FRANCE
PROVINCE COUNTRY: I0
ZIP: 13009
BUSINESS PHONE: 33430303030
MAIL ADDRESS:
ADDRESS IS A NON US LOCATION: YES
STREET 1: 117 AVENUE DE LUMINY
STREET 2: BP 30191
CITY: MARSEILLE
NON US STATE TERRITORY: FRANCE
PROVINCE COUNTRY: I0
ZIP: 13009
FORMER COMPANY:
FORMER CONFORMED NAME: Innate Pharma, SA
DATE OF NAME CHANGE: 20140129
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVO NORDISK A S
CENTRAL INDEX KEY: 0000353278
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
EIN: 000000000
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G/A
BUSINESS ADDRESS:
STREET 1: NOVO ALLE DK 2880
CITY: BAGSVAERD DENMARK
STATE: G7
ZIP: 00000
BUSINESS PHONE: 4544448888
MAIL ADDRESS:
STREET 1: NOVO ALLE DK 2880
CITY: BAGSVAERD DENMARK
STATE: G7
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: NOVO NORDISK A/S
DATE OF NAME CHANGE: 19900807
FORMER COMPANY:
FORMER CONFORMED NAME: NOVO INDUSTRI A S /DENMARK/
DATE OF NAME CHANGE: 19890811
SCHEDULE 13G/A
1
primary_doc.xml
SCHEDULE 13G/A
0000950103-20-001698
0000353278
XXXXXXXX
LIVE
1
Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares)
07/14/2025
0001598599
Innate Pharma SA
45781K105
117 Avenue de Luminy
BP 30191
Marseille
I0
13009
Rule 13d-1(d)
Novo Nordisk A/S
G7
8895649.00
0.00
8895649.00
0.00
8895649.00
N
9.65
CO
Innate Pharma SA
117 Avenue de Luminy, BP 30191, Marseille, France, 13009
Novo Nordisk A/S
Novo Alle 1, DK-2880, Bagsvaerd Denmark
Denmark
Y
8,895,649
9.65%
8,895,649
0
8,895,649
0
Y
Y
Y
Y
Y
Y
Novo Nordisk A/S
/s/ Karsten Munk Knudsen
Karsten Munk Knudsen, Chief Financial Officer
10/21/2025